SMLN.DE vs. FBT.L
Compare and contrast key facts about Invesco JPX-Nikkei 400 UCITS ETF (SMLN.DE) and First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L).
SMLN.DE and FBT.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. SMLN.DE is a passively managed fund by Invesco that tracks the performance of the JPX-Nikkei 400. It was launched on Sep 10, 2014. FBT.L is a passively managed fund by First Trust that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on May 27, 2020. Both SMLN.DE and FBT.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
SMLN.DE vs. FBT.L - Performance Comparison
Loading graphics...
SMLN.DE vs. FBT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
SMLN.DE Invesco JPX-Nikkei 400 UCITS ETF | 7.53% | 12.69% | 12.93% | 16.15% | -11.17% | 8.51% | 13.71% |
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | -2.02% | 11.35% | 12.25% | 0.68% | -1.22% | 3.77% | -2.13% |
Different Trading Currencies
SMLN.DE is traded in EUR, while FBT.L is traded in GBp. To make them comparable, the FBT.L values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, SMLN.DE achieves a 7.53% return, which is significantly higher than FBT.L's -2.02% return.
SMLN.DE
- 1D
- -1.77%
- 1M
- -2.32%
- YTD
- 7.53%
- 6M
- 10.46%
- 1Y
- 29.83%
- 3Y*
- 14.60%
- 5Y*
- 7.60%
- 10Y*
- 8.77%
FBT.L
- 1D
- -0.23%
- 1M
- 0.02%
- YTD
- -2.02%
- 6M
- 9.06%
- 1Y
- 18.67%
- 3Y*
- 7.16%
- 5Y*
- 4.72%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SMLN.DE vs. FBT.L - Expense Ratio Comparison
SMLN.DE has a 0.19% expense ratio, which is lower than FBT.L's 0.60% expense ratio.
Return for Risk
SMLN.DE vs. FBT.L — Risk / Return Rank
SMLN.DE
FBT.L
SMLN.DE vs. FBT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco JPX-Nikkei 400 UCITS ETF (SMLN.DE) and First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SMLN.DE | FBT.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.20 | 0.63 | +0.56 |
Sortino ratioReturn per unit of downside risk | 1.74 | 1.05 | +0.69 |
Omega ratioGain probability vs. loss probability | 1.24 | 1.13 | +0.11 |
Calmar ratioReturn relative to maximum drawdown | 3.17 | 0.73 | +2.43 |
Martin ratioReturn relative to average drawdown | 10.72 | 1.70 | +9.02 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SMLN.DE | FBT.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.20 | 0.63 | +0.56 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | 0.29 | +0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.54 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.23 | +0.26 |
Correlation
The correlation between SMLN.DE and FBT.L is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SMLN.DE vs. FBT.L - Dividend Comparison
Neither SMLN.DE nor FBT.L has paid dividends to shareholders.
Drawdowns
SMLN.DE vs. FBT.L - Drawdown Comparison
The maximum SMLN.DE drawdown since its inception was -28.42%, which is greater than FBT.L's maximum drawdown of -26.40%. Use the drawdown chart below to compare losses from any high point for SMLN.DE and FBT.L.
Loading graphics...
Drawdown Indicators
| SMLN.DE | FBT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.42% | -30.39% | +1.97% |
Max Drawdown (1Y)Largest decline over 1 year | -9.43% | -13.81% | +4.38% |
Max Drawdown (5Y)Largest decline over 5 years | -19.85% | -23.70% | +3.85% |
Max Drawdown (10Y)Largest decline over 10 years | -28.42% | — | — |
Current DrawdownCurrent decline from peak | -5.98% | -8.01% | +2.03% |
Average DrawdownAverage peak-to-trough decline | -6.08% | -13.72% | +7.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.78% | 6.03% | -3.25% |
Volatility
SMLN.DE vs. FBT.L - Volatility Comparison
Invesco JPX-Nikkei 400 UCITS ETF (SMLN.DE) has a higher volatility of 8.32% compared to First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) at 6.87%. This indicates that SMLN.DE's price experiences larger fluctuations and is considered to be riskier than FBT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SMLN.DE | FBT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.32% | 6.87% | +1.45% |
Volatility (6M)Calculated over the trailing 6-month period | 14.31% | 14.62% | -0.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.73% | 22.83% | -3.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.99% | 23.07% | -7.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.27% | 24.39% | -8.12% |